Halozyme (HALO +3%) gets a boost from positive comments out of JMP Securities today. The firm...

|About: Halozyme Therapeutics, Inc. (HALO)|By:, SA News Editor

Halozyme (HALO +3%) gets a boost from positive comments out of JMP Securities today. The firm says the drug developer's SC Cinryze treatment and its aesthetic medicine candidate HTI-501 are both undergoing Phase II tests, and are likely to drive the stock higher in 2012.